Gene Therapy Stream - The Bioprocessing Summit

STREAM #3
GENE THERAPY

The Gene Therapy stream focuses on the critical challenges facing the analysis, characterization, quality control and manufacture of gene therapies, viral and non-viral based. Topics include product and process characterization, potency assays, comparability, emerging analytical technologies, impurities, quality control, comparability, process development, purification, formulation, scale-up and commercial manufacturing.

Conferences Include:

Gene Therapy CMC and Analytics

Gene Therapy Manufacturing

Keynote and Featured Presentations

CMC Strategies for Process Intensification and Acceleration of IND Submission for Gene Therapies
Srinivas Chollangi, PhD, Director, Cell and Gene Therapy CMC, Sanofi

Phased Approach to Establishing Production Platforms
Terrence Dobrowsky, PhD, Head, Gene Therapy Drug Substance, Biogen

Production of AAV Vectors: Process Optimization towards Commercialization
Barbara Kraus, PhD, Head, Gene Therapy Process Development, Takeda

What Is in Those Capsids? AAV Capsid Content Is an Attribute with Many Measures
Herbert A. Runnels, PhD, Global CMC AAV Analytical Sponsor, Gene Therapy, Pfizer Inc.